KINDSTAR GLOBALGENE TECHNOLOGY INC revenue breakdown overview

KINDSTAR GLOBALGENE TECHNOLOGY INC revenue for the last year amounted to 1.06 B HKD, the most of which — 652.29 M HKD — came from its highest performing source at the moment, Hematology Testing, the year earlier bringing 611.44 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought KINDSTAR GLOBALGENE TECHNOLOGY INC 1.07 B HKD, and the year before that — 1.61 B HKD.